Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
The Jakarta Post
Video Weather icon 30°C
DKI Jakarta, Indonesia
weather-icon
30°C Partly Cloudy

Dry and mostly cloudy throughout the day.

  • weather-icon

    Wed

    26℃ - 32℃

  • weather-icon

    Thu

    25℃ - 32℃

  • weather-icon

    Fri

    25℃ - 31℃

  • weather-icon

    Sat

    26℃ - 30℃

China approves 17 anti-cancer drugs for medical insurance coverage

  •  

    Reuters

Shanghai | Wed, October 10, 2018 | 08:26 am
China approves 17 anti-cancer drugs for medical insurance coverage Cancer awareness: Participants of the 2018 Anyo Gold Ribbon Configuration form a huge yellow ribbon in Jakarta as part of a campaign for International Childhood Cancer Awareness Month in September. (Courtesy of the Indonesian Anyo Foundation/-)

China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said on Wednesday, part of its efforts to make cancer treatment more affordable as the number of cases increases.

China's State Medical Insurance Administration has been in negotiations with domestic and overseas pharmaceutical companies to lower prices and put more cancer drugs on the list of medicines eligible for reimbursement.

The administration said in a notice that the negotiations were a major part of the government's strategy to make cancer drugs more affordable to the general public. The 17 drugs, which include azacitidine, will remain eligible until Nov. 30, 2020.

China's cancer rates have been soaring, driven by growing numbers of over-60s, heavy smoking among men and exposure to pollution. The National Cancer Center said last year there were 4.29 million new cases every year and 2.81 million deaths.

China has vowed to improve the five-year cancer survival rate by 15 percentage points by 2030. The rate stood at 30 percent in 2015, half the U.S. level.

Join the discussions